Position in RVTY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$645,753
+$147,077 QoQ
Shares Held
5,804
+2.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#245
of 538 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in RVTY Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026ANGELES WEALTH MANAGEMENT, LLC holds $6,564,865 across 7 Diagnostics & Research names. RVTY ranks #4 (9.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
5,035 | $2,524,347 | |
| 2 | DHR |
Danaher Corp /De/
|
7,237 | $1,378,503 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
1,393 | $733,330 | |
| 4 | RVTY |
Revvity, Inc.
This page
|
5,804 | $645,753 | |
| 5 | LH |
Labcorp Holdings Inc.
|
1,924 | $538,720 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
916 | $485,104 | |
| 7 | IQV |
Iqvia Holdings Inc.
|
1,341 | $259,108 |
All Filings in RVTY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $645,753 | 5,804 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $498,676 | 5,692 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $550,894 | 5,694 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $499,780 | 5,702 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $564,651 | 5,838 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $609,725 | 5,763 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $642,315 | 5,755 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $734,434 | 5,749 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $601,162 | 5,733 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $597,765 | 5,693 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $624,050 | 5,709 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||